Business Description
Rhythm Biosciences Ltd
ISIN : AU000000RHY2
Share Class Description:
FRA:0RY: Ordinary SharesDescription
Rhythm Biosciences Ltd is an Australian medical diagnostics company with a focus on delivering simple, affordable blood tests for the accurate detection of cancers, providing physicians with accurate and reliable diagnostic tools. Its ColoSTAT is designed to complement clinical assessment by helping determine which patients may benefit from further investigation, such as colonoscopy. The company operates predominantly in one business being the development and commercialization of cancer diagnostic tests in Victoria, Australia and the United States of America.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 13.87 | |||||
Equity-to-Asset | 0.76 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | -0.04 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -1.71 | |||||
Beneish M-Score | -2.2 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 30.7 | |||||
3-Year EPS without NRI Growth Rate | 21.4 | |||||
3-Year FCF Growth Rate | 20.6 | |||||
3-Year Book Growth Rate | -27.3 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 41.97 | |||||
9-Day RSI | 46.36 | |||||
14-Day RSI | 47.82 | |||||
3-1 Month Momentum % | -33.33 | |||||
6-1 Month Momentum % | -56.73 | |||||
12-1 Month Momentum % | 2.27 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.61 | |||||
Quick Ratio | 3.59 | |||||
Cash Ratio | 3.3 | |||||
Days Inventory | 55.09 | |||||
Days Sales Outstanding | 717.12 | |||||
Days Payable | 459.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -17.5 | |||||
Shareholder Yield % | -26.97 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -323.53 | |||||
Operating Margin % | -8774.12 | |||||
Net Margin % | -6976.47 | |||||
EBITDA Margin % | -6665.88 | |||||
FCF Margin % | -6226 | |||||
OCF Margin % | -6194 | |||||
ROE % | -276.24 | |||||
ROA % | -166.14 | |||||
ROIC % | -438.79 | |||||
3-Year ROIIC % | -706.57 | |||||
ROC (Joel Greenblatt) % | -3745.84 | |||||
ROCE % | -267.6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 8.7 | |||||
Price-to-Tangible-Book | 5.1 | |||||
EV-to-EBIT | -4.72 | |||||
EV-to-EBITDA | -4.88 | |||||
EV-to-Revenue | 325.14 | |||||
EV-to-FCF | -5.11 | |||||
| Price-to-Net-Current-Asset-Value | 5.1 | |||||
| Price-to-Net-Cash | 5.1 | |||||
Earnings Yield (Greenblatt) % | -21.2 | |||||
FCF Yield % | -17.05 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rhythm Biosciences Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.05 | ||
| EPS (TTM) (€) | -0.01 | ||
| Beta | 1.224 | ||
| 3-Year Sharpe Ratio | -0.29 | ||
| 3-Year Sortino Ratio | -0.47 | ||
| Volatility % | 95.38 | ||
| 14-Day RSI | 47.82 | ||
| 14-Day ATR (€) | 0.002589 | ||
| 20-Day SMA (€) | 0.052325 | ||
| 12-1 Month Momentum % | 2.27 | ||
| 52-Week Range (€) | 0.0415 - 0.144 | ||
| Shares Outstanding (Mil) | 353.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Rhythm Biosciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Rhythm Biosciences Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Rhythm Biosciences Ltd Frequently Asked Questions
What is Rhythm Biosciences Ltd(FRA:0RY)'s stock price today?
The current price of FRA:0RY is €0.05. The 52 week high of FRA:0RY is €0.14 and 52 week low is €0.04.
When is next earnings date of Rhythm Biosciences Ltd(FRA:0RY)?
The next earnings date of Rhythm Biosciences Ltd(FRA:0RY) is .
Does Rhythm Biosciences Ltd(FRA:0RY) pay dividends? If so, how much?
Rhythm Biosciences Ltd(FRA:0RY) does not pay dividend.
Press Release
Articles on Rhythm Biosciences Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers